Friday 6 November 2026 Export LMAT’s income statement to Excel — free account

LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue: +11.3%
EPS: −14.3%
Free cash flow: −25.8%
Total debt: +0.53%

Quarter to September 2026, against a year earlier

80.60 2.89 −3.46%

Follow LMAT

Alert me

Market cap: $1.9B
P/E: 29.7×
Fwd P/E: 28.2×
Dividend yield: 1.15%
F-score: 6/9
Altman Z: 6.99
Beneish M: −2.61
Dividend safety: 93/100

Overview

LeMaitre Vascular, Inc. (LMAT) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, LeMaitre Vascular, Inc. (LMAT) trades at a price to free cash flow of 28.3×. Over the past ten years it has ranged from 21.3× (July 2016) to 79.6× (June 2023); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 23.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LMAT/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="LeMaitre Vascular, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LMAT/metrics/price-to-free-cash-flow">LeMaitre Vascular, Inc. (LMAT) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	24.7×	(55.73%)
FY2024	55.7×	30.26%
FY2023	42.8×	(1.55%)
FY2022	43.4×	23.42%
FY2021	35.2×	45.15%
FY2020	24.2×	(64.62%)
FY2019	68.5×	145.15%
FY2018	28.0×	(22.18%)
FY2017	35.9×	8.07%
FY2016	33.2×	(0.69%)

Period	Price to free cash flow	Change
Sep 2026	28.2×	(5.11%)
Jun 2026	29.7×	(5.56%)
Mar 2026	31.5×	27.60%
Dec 2025	24.7×	(17.67%)
43 more quarters	Free account

Against its own ten years

Low 21.3× High 79.6×

Ten-year median 36.2×

Current reading's percentile 18

Company	Price to free cash flow
STVN Stevanato Group S.p.A. compare	n/m
PLSE Pulse Biosciences, Inc compare	n/m
KMTS Kestra Medical Technologies, Ltd. compare	n/m
XRAY DENTSPLY SIRONA Inc. compare	21.1×
LMAT LeMaitre Vascular, Inc.	28.3×
STAA STAAR Surgical Company compare	75.3×
ATRC AtriCure, Inc. compare	129×
WRBY Warby Parker Inc. compare	153×
AZTA Azenta, Inc. compare	172×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

LeMaitre Vascular, Inc. (LMAT) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on LMAT

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on LMAT

Stockrow Weekly